citalopram has been researched along with Hallucinations in 21 studies
Citalopram: A furancarbonitrile that is one of the serotonin uptake inhibitors used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from TARDIVE DYSKINESIA in preference to tricyclic antidepressants, which aggravate dyskinesia.
citalopram : A racemate comprising equimolar amounts of (R)-citalopram and its enantiomer, escitalopram. It is used as an antidepressant, although only escitalopram is active.
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile : A nitrile that is 1,3-dihydro-2-benzofuran-5-carbonitrile in which one of the hydrogens at position 1 is replaced by a p-fluorophenyl group, while the other is replaced by a 3-(dimethylamino)propyl group.
Hallucinations: Subjectively experienced sensations in the absence of an appropriate stimulus, but which are regarded by the individual as real. They may be of organic origin or associated with MENTAL DISORDERS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Escitalopram was well tolerated, and the only detected side effects, nausea and headache, were mild and transient." | 5.40 | The beneficial effect of escitalopram on obsessive-compulsive-related musical hallucinations in elderly patients with hearing impairment: a case series. ( Bergman, J; Pashinian, A; Poyurovsky, M; Weizman, A, 2014) |
| "While dosage constraints must be considered because of citalopram's adverse effect profile, this agent's overall therapeutic effects in patients with Alzheimer's disease and agitation, in addition to efficacy for agitation/aggression, included reductions in the frequency of irritability, anxiety, and delusions; among patients who had these symptoms at week 9, they included a reduction in the severity of hallucinations but an increase in the severity of sleep/nighttime behavior disorders." | 5.22 | Effects of Citalopram on Neuropsychiatric Symptoms in Alzheimer's Dementia: Evidence From the CitAD Study. ( Devanand, DP; Drye, LT; Frangakis, C; Leonpacher, AK; Lyketsos, CG; Makino, KM; Mintzer, JE; Munro, CA; Newell, JA; Peters, ME; Pollock, BG; Porsteinsson, AP; Rosenberg, PB; Schneider, LS; Shade, DM; Weintraub, D; Yesavage, J, 2016) |
| "To ascertain the impact of treatment with citalopram on irritability, apathy, delusions, and hallucinations in nondepressed behaviorally disturbed Alzheimer's disease (AD) patients." | 3.75 | Effect of a serotonin reuptake inhibitor on irritability, apathy, and psychotic symptoms in patients with Alzheimer's disease. ( Hynan, LS; Siddique, H; Weiner, MF, 2009) |
| "Turner syndrome encompasses several chromosomal abnormalities and includes a typical clinical manifestation." | 2.45 | [Turner-syndrome and psychosis: a case report and brief review of the literature]. ( Preuss, UW; Wustmann, T, 2009) |
| "Escitalopram was well tolerated, and the only detected side effects, nausea and headache, were mild and transient." | 1.40 | The beneficial effect of escitalopram on obsessive-compulsive-related musical hallucinations in elderly patients with hearing impairment: a case series. ( Bergman, J; Pashinian, A; Poyurovsky, M; Weizman, A, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (38.10) | 29.6817 |
| 2010's | 13 (61.90) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abeysundera, H | 1 |
| Gill, R | 1 |
| Bergman, Y | 1 |
| Barak, Y | 1 |
| Hanck, L | 1 |
| Schellekens, AF | 1 |
| Waltereit, R | 1 |
| Eifler, S | 1 |
| Schirmbeck, F | 1 |
| Zink, M | 1 |
| Michael, S | 1 |
| Boulton, M | 1 |
| Andrews, G | 1 |
| Bergman, J | 1 |
| Pashinian, A | 1 |
| Weizman, A | 1 |
| Poyurovsky, M | 1 |
| Kogoj, A | 1 |
| Masmoudi, J | 1 |
| Feki, I | 1 |
| Trigui, D | 1 |
| Baati, I | 1 |
| Jaoua, A | 1 |
| Leonpacher, AK | 1 |
| Peters, ME | 1 |
| Drye, LT | 1 |
| Makino, KM | 1 |
| Newell, JA | 1 |
| Devanand, DP | 1 |
| Frangakis, C | 1 |
| Munro, CA | 1 |
| Mintzer, JE | 1 |
| Pollock, BG | 1 |
| Rosenberg, PB | 1 |
| Schneider, LS | 1 |
| Shade, DM | 1 |
| Weintraub, D | 1 |
| Yesavage, J | 1 |
| Lyketsos, CG | 1 |
| Porsteinsson, AP | 1 |
| Abouchedid, R | 1 |
| Ho, JH | 1 |
| Hudson, S | 1 |
| Dines, A | 1 |
| Archer, JR | 1 |
| Wood, DM | 1 |
| Dargan, PI | 1 |
| Ozturk, A | 1 |
| Yasar, H | 1 |
| Gulsun, M | 1 |
| Balıkcı, A | 1 |
| Bozoglu, E | 1 |
| Naharcı, MI | 1 |
| Boyraz, O | 1 |
| Oztın, H | 1 |
| Doruk, H | 1 |
| Vesteinsdottir, E | 1 |
| Matthiasson, P | 1 |
| Wustmann, T | 1 |
| Preuss, UW | 1 |
| Siddique, H | 1 |
| Hynan, LS | 1 |
| Weiner, MF | 1 |
| Mowla, A | 1 |
| Khosravizadegan, F | 1 |
| Ebrahimi, AA | 1 |
| Sabayan, B | 1 |
| Pani, A | 1 |
| Vetrugno, R | 1 |
| Vella, A | 1 |
| Mascalchi, M | 1 |
| Alessandria, M | 1 |
| D'Angelo, R | 1 |
| Gallassi, R | 1 |
| Della Nave, R | 1 |
| Ginestroni, A | 1 |
| Antelmi, E | 1 |
| Montagna, P | 1 |
| Wand, AP | 1 |
| Lai, CH | 1 |
| Di Michele, V | 1 |
| Bolino, F | 1 |
| Kessler, H | 1 |
| Kraft, S | 1 |
| Dollfus, S | 1 |
| Larmurier-Montagne, A | 1 |
| Razafimandimby, A | 1 |
| Allio, G | 1 |
| Membrey, JM | 1 |
| Delcroix, N | 1 |
| Etard, O | 1 |
3 reviews available for citalopram and Hallucinations
| Article | Year |
|---|---|
Selective serotonin reuptake inhibitors-induced delirium: a case review.
Topics: Aged; Aged, 80 and over; Bipolar Disorder; Citalopram; Delirium; Dose-Response Relationship, Drug; D | 2014 |
[Turner-syndrome and psychosis: a case report and brief review of the literature].
Topics: Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Chromosome Aberrati | 2009 |
[Neuropsychiatric symptoms in Sotos syndrome. Case report and review of the literature].
Topics: Adult; Antipsychotic Agents; Brain; Carbamazepine; Chromosome Deletion; Citalopram; Compulsive Behav | 2008 |
1 trial available for citalopram and Hallucinations
| Article | Year |
|---|---|
Effects of Citalopram on Neuropsychiatric Symptoms in Alzheimer's Dementia: Evidence From the CitAD Study.
Topics: Alzheimer Disease; Antidepressive Agents, Second-Generation; Anxiety; Citalopram; Delusions; Female; | 2016 |
17 other studies available for citalopram and Hallucinations
| Article | Year |
|---|---|
Possible SAMe-induced mania.
Topics: Adult; Bipolar Disorder; Citalopram; Depression; Drug Therapy, Combination; Female; Hallucinations; | 2018 |
Escitalopram for antipsychotic nonresponsive visual hallucinosis: eight patients suffering from Charles Bonnet syndrome.
Topics: Aged, 80 and over; Citalopram; Eye Diseases; Female; Hallucinations; Humans; Male; Psychotic Disorde | 2013 |
[Hallucinogen persisting perception disorder after ecstasy use].
Topics: Anxiety Disorders; Citalopram; Depressive Disorder; Hallucinations; Hallucinogens; Humans; Male; N-M | 2013 |
Visual and auditory hallucinations associated with citalopram treatment.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Citalopram; Depressive D | 2013 |
Two cases of olfactory reference syndrome responding to an atypical antipsychotic and SSRI.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Citalopram; Delusions; Drug Therapy, Combination; Female; | 2014 |
The beneficial effect of escitalopram on obsessive-compulsive-related musical hallucinations in elderly patients with hearing impairment: a case series.
Topics: Aged; Aged, 80 and over; Aging; Citalopram; Female; Hallucinations; Hearing Loss; Humans; Male; Musi | 2014 |
[Complex visual hallucinations secondary to corneal transplant: The Charles Bonnet syndrome].
Topics: Aged; Antidepressive Agents, Second-Generation; Citalopram; Corneal Transplantation; Hallucinations; | 2015 |
Acute Toxicity Associated with Use of 5F-Derivations of Synthetic Cannabinoid Receptor Agonists with Analytical Confirmation.
Topics: Adamantane; Administration, Intravenous; Anti-Anxiety Agents; Cannabinoid Receptor Agonists; Citalop | 2016 |
Remission in visual hallucinatory experiences after citalopram treatment in a patient with dementia.
Topics: Citalopram; Dementia; Hallucinations; Humans; Remission Induction | 2017 |
[Case of the month. A malignant brain tumor presenting with depression and hallucinations].
Topics: Antidepressive Agents, Second-Generation; Brain Neoplasms; Citalopram; Depression; Glioblastoma; Hal | 2008 |
Effect of a serotonin reuptake inhibitor on irritability, apathy, and psychotic symptoms in patients with Alzheimer's disease.
Topics: Alzheimer Disease; Antipsychotic Agents; Citalopram; Delusions; Drug Therapy, Combination; Hallucina | 2009 |
Citalopram associated with complex visual hallucination: a case report.
Topics: Aged; Antidepressive Agents, Second-Generation; Citalopram; Depression; Female; Hallucinations; Huma | 2009 |
Peduncular hallucinosis: a polysomnographic and spect study of a patient and efficacy of serotonergic therapy.
Topics: Aged; Awareness; Brain Ischemia; Carotid Artery Diseases; Carotid Artery, Internal; Citalopram; Dila | 2009 |
Transient citalopram-induced auditory hallucinations in a patient with Parkinson's disease and depression.
Topics: Aged, 80 and over; Antidepressive Agents, Second-Generation; Citalopram; Depressive Disorder, Major; | 2012 |
Escitalopram-related visual and auditory hallucination in a non-dementia patient with depression.
Topics: Aged; Antidepressive Agents, Second-Generation; Citalopram; Depressive Disorder; Hallucinations; Hum | 2012 |
Adjunctive citalopram is effective on hallucinations and depersonalization symptoms: a case report.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Citalopram; Depersonalization; Drug Therapy, Combinati | 2004 |
Treatment of auditory hallucinations by combining high-frequency repetitive transcranial magnetic stimulation and functional magnetic resonance imaging.
Topics: Antidepressive Agents; Antipsychotic Agents; Citalopram; Combined Modality Therapy; Comorbidity; Dep | 2008 |